Current Allergy and Asthma Reports

, Volume 11, Issue 1, pp 65–70 | Cite as

Epinephrine Autoinjector Refill History in an HMO

  • Michael S. Kaplan
  • Sandy Y. Jung
  • Matthew L. Chiang
Article

Abstract

Epinephrine can be lifesaving in episodes of anaphylaxis, yet it is underprescribed and underused. Tracking of epinephrine refills over time for patients with a diagnosis of anaphylaxis has not been reported. This study reports on the refill history of 14,677 patients in a large HMO who received an initial dispensing of EpiPen (Dey Pharma, Basking Ridge, NJ) or EpiPen Jr between 2000 and 2006. A total of 6,776 (46%) refilled at least once. Twenty-five percent of the patients who were in the cohort for 5 years or more refilled multiple times, and 11% refilled consistently at all expected refill times. Infants through children 12 years of age were more likely to receive a refill dispensing (63%) compared with teenagers and adults (40%). The most common ICD-9 codes that were linked to the initial epinephrine dispensing were allergic disorder (37%), miscellaneous anaphylaxis/angioedema (23%), hymenoptera/insect bite or sting (14%), and specific or nonspecific food allergy (11%). A total of 79% of patients with a food-related ICD-9 code and 59% of patients with an insect sting-related ICD-9 code refilled epinephrine at least once. An opportunity exists to identify system-based as well as personal barriers in an ongoing effort to provide patients at risk with the tools and empowerment that could reduce their risk during life-threatening anaphylactic reactions.

Keywords

Anaphylaxis Severe allergic reaction Epinephrine autoinjector 

Notes

Disclosure

Dr. Kaplan has served on an advisory board for Dey Pharma. Drs. Jung and Chiang reported no potential conflicts of interest relevant to this article.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Vander Leek TK, Liu AH, Stefanski K, et al.: The natural history of peanut allergy in young children and in association with serum peanut specific IgE. J Pediatr 2000, 137:749–755.CrossRefPubMedGoogle Scholar
  2. 2.
    Mullins RJ: Anaphylaxis: risk factors for recurrence. Exp Allergy 2003, 33:1033–1040.CrossRefGoogle Scholar
  3. 3.•
    Simons, FER, Clark S, Camargo CA: Anaphylaxis in the community: learning from the survivors. J Allergy Clin Immunol 2009, 124:301–306. This article offers insight into the barriers that affected the decisions of patients or their caretakers to use or not to use epinephrine. The information is useful in helping to design patient education programs for populations at risk of anaphylaxis. CrossRefPubMedGoogle Scholar
  4. 4.
    Haymore BR: Anaphylaxis and epinephrine prescribing patterns in a military hospital: underutilization of the intramuscular route. Allergy Asthma Proc 2005, 26:361–365.PubMedGoogle Scholar
  5. 5.•
    Simons KJ: Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol 2010, 10:354–361. This is an excellent review of epinephrine use in the community, including prescribing behaviors of providers. It explores the question of who may need an autoinjector and why patients elect not to self-inject. CrossRefPubMedGoogle Scholar
  6. 6.
    Johnson TL, Parker AL: Rate of retrieval of self-injector epinephrine prescriptions: a descriptive report. Ann Allergy Asthma Immunol 2006, 97:694–697.CrossRefPubMedGoogle Scholar
  7. 7.
    Campbell RL, Luke A, Weaver AL, et al.: Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol 2008, 101:631–636.CrossRefPubMedGoogle Scholar
  8. 8.
    Kim JS, Sinacore JM, Pongracic JA: Parental use of EpiPen for children with food allergies. J Allergy Clin Immunol 2005, 116:164–168.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Michael S. Kaplan
    • 1
  • Sandy Y. Jung
    • 1
  • Matthew L. Chiang
    • 1
  1. 1.Department of Allergy and Clinical Immunology, Kaiser PermanenteLos Angeles Medical CenterLos AngelesUSA

Personalised recommendations